Vanguard Capital Management
MIRM icon

Vanguard Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Vanguard Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264M Sell
2,254,109
-160,667
-7% -$16.1M 0.01% 975
2026
Q1 		$223M Buy
+2,414,776
New +$227M 0.01% 1009

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management's MIRM Position: Q2 2026 in Review

Vanguard Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 6.7% in Q2 2026, selling an estimated $16.1M and leaving 2,254,109 shares worth $264M. The position accounts for 0.01% of the portfolio, ranked #975.

Vanguard Capital Management first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Vanguard Capital Management held 2,254,109 shares of Mirum Pharmaceuticals worth $264M as of Q2 2026.
  • Vanguard Capital Management sold 160,667 Mirum Pharmaceuticals shares in Q2 2026, an estimated $16.1M.
  • Mirum Pharmaceuticals made up 0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #975 holding.
  • Vanguard Capital Management first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 300 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.